title: The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
authors.forename: T
authors.initials: T
authors.lastname: Arayssi
authors.forename: R
authors.initials: R
authors.lastname: Hamra
authors.forename: F
authors.initials: F
authors.lastname: Homeidan
authors.forename: I
authors.initials: I
authors.lastname: Uthman
authors.forename: S T
authors.initials: ST
authors.lastname: Awwad
authors.forename: K
authors.initials: K
authors.lastname: Mroue
authors.forename: W
authors.initials: W
authors.lastname: Mansour
authors.forename: Z F
authors.initials: ZF
authors.lastname: Bashshur
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome; D014606:Uveitis, Anterior / Q000188:drug therapy* / Q000209:etiology; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000209:etiology; D014822:Vitreous Body / Q000187:drug effects / Q000503:physiopathology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D011241:Prednisone